Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uriel Halbreich

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
CNS Drugs|June 28, 2006
Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?Uriel Halbreich, P M Shaughn O'Brien, Elias Eriksson, et al.
Expert Review of Neurotherapeutics|December 6, 2007
Neurobehavioral impact of menopause on moodJeanne Leventhal Alexander, Lorraine Dennerstein, Nancy Fugate Woods, et al.
Obstetrics and Gynecology|September 11, 2002
Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diariesLee S Cohen, Cherri Miner, Eileen W Brown, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 23, 2018
Grave Concerns Expressed by Psychiatrists Over Current Immigration PoliciesHossam Mahmoud, James L Fleming, Uriel Halbreich, et al.
Expert Review of Neurotherapeutics|December 6, 2007
Role of stressful life events and menopausal stage in wellbeing and healthJeanne Leventhal Alexander, Lorraine Dennerstein, Nancy Fugate Woods, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 4, 2021
Psychological distress and sleep problems in healthcare workers in a developing context during COVID-19 pandemic: Implications for workplace wellbeingAndrew T Olagunju, Ayodeji A Bioku, Tinuke O Olagunju, et al.
Contraception|December 14, 2011
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndromeEllen W Freeman, Uriel Halbreich, Gary S Grubb, et al.
Expert Review of Neurotherapeutics|December 6, 2007
Arthralgias, bodily aches and pains and somatic complaints in midlife women: etiology, pathophysiology and differential diagnosisJeanne Leventhal Alexander, Lorraine Dennerstein, Louise Dennerstein, et al.
Contraception|November 10, 2011
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorderUriel Halbreich, Ellen W Freeman, Andrea J Rapkin, et al.
BMC Women'S Health|June 7, 2011
Premenstrual symptoms in young adults born preterm at very low birth weight--from the Helsinki Study of Very Low Birth Weight AdultsSanna Mustaniemi, Marika Sipola-Leppänen, Petteri Hovi, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
CNS Drugs|June 28, 2006
Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?Uriel Halbreich, P M Shaughn O'Brien, Elias Eriksson, et al.
Expert Review of Neurotherapeutics|December 6, 2007
Neurobehavioral impact of menopause on moodJeanne Leventhal Alexander, Lorraine Dennerstein, Nancy Fugate Woods, et al.
Obstetrics and Gynecology|September 11, 2002
Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diariesLee S Cohen, Cherri Miner, Eileen W Brown, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 23, 2018
Grave Concerns Expressed by Psychiatrists Over Current Immigration PoliciesHossam Mahmoud, James L Fleming, Uriel Halbreich, et al.
Expert Review of Neurotherapeutics|December 6, 2007
Role of stressful life events and menopausal stage in wellbeing and healthJeanne Leventhal Alexander, Lorraine Dennerstein, Nancy Fugate Woods, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 4, 2021
Psychological distress and sleep problems in healthcare workers in a developing context during COVID-19 pandemic: Implications for workplace wellbeingAndrew T Olagunju, Ayodeji A Bioku, Tinuke O Olagunju, et al.
Contraception|December 14, 2011
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndromeEllen W Freeman, Uriel Halbreich, Gary S Grubb, et al.
Expert Review of Neurotherapeutics|December 6, 2007
Arthralgias, bodily aches and pains and somatic complaints in midlife women: etiology, pathophysiology and differential diagnosisJeanne Leventhal Alexander, Lorraine Dennerstein, Louise Dennerstein, et al.
Contraception|November 10, 2011
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorderUriel Halbreich, Ellen W Freeman, Andrea J Rapkin, et al.
BMC Women'S Health|June 7, 2011
Premenstrual symptoms in young adults born preterm at very low birth weight--from the Helsinki Study of Very Low Birth Weight AdultsSanna Mustaniemi, Marika Sipola-Leppänen, Petteri Hovi, et al.
Pageof 6